articleRadiologyJun 27, 2016Closed access

Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer

Southern Medical University · Guangdong Academy of Medical Sciences · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Purpose To develop a radiomics signature to estimate disease-free survival (DFS) in patients with early-stage (stage I–II) non–small cell lung cancer (NSCLC) and assess its incremental value to the traditional staging system and clinical-pathologic risk factors for individual DFS estimation. Materials and Methods Ethical approval by the institutional review board was obtained for this retrospective analysis, and the need to obtain informed consent was waived. This study consisted of 282 consecutive patients with stage IA–IIB NSCLC. A radiomics signature was generated by using the least absolute shrinkage and selection operator, or LASSO, Cox regression model. Association between the radiomics signature and DFS…

No related works found for this paper.

Funding